Liver Cancer Clinical Trials

A listing of Liver Cancer medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.

 

California

UPDATED

Daly City California 94115

A Phase 3 clinical study for patients with Hepatocellular Carcinoma and Elevated Baseline Alpha-Fetoprotein

UPDATED

Los Angeles California 90024

A Phase 3 clinical study for patients with Hepatocellular Carcinoma and Elevated Baseline Alpha-Fetoprotein

Iowa

UPDATED

Iowa City Iowa 52242

A Phase 3 clinical study for patients with Hepatocellular Carcinoma and Elevated Baseline Alpha-Fetoprotein

Massachusetts

UPDATED

Boston Massachusetts 02114

A Phase 3 clinical study for patients with Hepatocellular Carcinoma and Elevated Baseline Alpha-Fetoprotein

Michigan

UPDATED

Detroit Michigan 48201

A clinical trial to evaluate treatments using PDR001 and Sorafenib for patients with Hepatocellular Carcinoma

New York

UPDATED

New York New York 10029

A Phase 3 clinical study for patients with Hepatocellular Carcinoma and Elevated Baseline Alpha-Fetoprotein

Oklahoma

UPDATED

Oklahoma City Oklahoma 73104

A Phase 3 clinical study for patients with Hepatocellular Carcinoma and Elevated Baseline Alpha-Fetoprotein

Oregon

UPDATED

Portland Oregon 97239

A Phase 3 clinical study for patients with Hepatocellular Carcinoma and Elevated Baseline Alpha-Fetoprotein

Australia

UPDATED

Kogarah 2217

A Phase 3 clinical study for patients with Hepatocellular Carcinoma and Elevated Baseline Alpha-Fetoprotein

UPDATED

Kurralta Park 5037

A Phase 3 clinical study for patients with Hepatocellular Carcinoma and Elevated Baseline Alpha-Fetoprotein

UPDATED

Melbourne 3181

A Phase 3 clinical study for patients with Hepatocellular Carcinoma and Elevated Baseline Alpha-Fetoprotein

UPDATED

Nedlands 6009

A Phase 3 clinical study for patients with Hepatocellular Carcinoma and Elevated Baseline Alpha-Fetoprotein

UPDATED

Woodville 5011

A Phase 3 clinical study for patients with Hepatocellular Carcinoma and Elevated Baseline Alpha-Fetoprotein

Austria

UPDATED

Linz 4020

A Phase 3 clinical study for patients with Hepatocellular Carcinoma and Elevated Baseline Alpha-Fetoprotein

UPDATED

Wien 1090

A Phase 3 clinical study for patients with Hepatocellular Carcinoma and Elevated Baseline Alpha-Fetoprotein

Belgium

UPDATED

Brussels 1200

A Phase 3 clinical study for patients with Hepatocellular Carcinoma and Elevated Baseline Alpha-Fetoprotein

UPDATED

Liège 4000

A Phase 3 clinical study for patients with Hepatocellular Carcinoma and Elevated Baseline Alpha-Fetoprotein

Brazil

UPDATED

Sao Jose Rio Preto 15090-000

A Phase 3 clinical study for patients with Hepatocellular Carcinoma and Elevated Baseline Alpha-Fetoprotein

UPDATED

Sao Paulo 15090-000

A Phase 3 clinical study for patients with Hepatocellular Carcinoma and Elevated Baseline Alpha-Fetoprotein

Canada

UPDATED

Montreal Quebec H3T 1E2

A clinical trial to evaluate treatments using PDR001 and Sorafenib for patients with Hepatocellular Carcinoma

UPDATED

Montreal H2X 3J4

A Phase 3 clinical study for patients with Hepatocellular Carcinoma and Elevated Baseline Alpha-Fetoprotein

UPDATED

Toronto M5G 2M9

A Phase 3 clinical study for patients with Hepatocellular Carcinoma and Elevated Baseline Alpha-Fetoprotein

China

UPDATED

Beijing

A Phase 3 clinical study for patients with Hepatocellular Carcinoma and Elevated Baseline Alpha-Fetoprotein

UPDATED

Heilongjiang 150081

A Phase 3 clinical study for patients with Hepatocellular Carcinoma and Elevated Baseline Alpha-Fetoprotein

UPDATED

Henan 450008

A Phase 3 clinical study for patients with Hepatocellular Carcinoma and Elevated Baseline Alpha-Fetoprotein

UPDATED

Shanghai

A Phase 3 clinical study for patients with Hepatocellular Carcinoma and Elevated Baseline Alpha-Fetoprotein

UPDATED

Wu Han 430030

A Phase 3 clinical study for patients with Hepatocellular Carcinoma and Elevated Baseline Alpha-Fetoprotein

Czechia

UPDATED

Brno 656 53

A Phase 3 clinical study for patients with Hepatocellular Carcinoma and Elevated Baseline Alpha-Fetoprotein

UPDATED

Praha 5 150 06

A Phase 3 clinical study for patients with Hepatocellular Carcinoma and Elevated Baseline Alpha-Fetoprotein

France

UPDATED

Amiens 80054

A Phase 3 clinical study for patients with Hepatocellular Carcinoma and Elevated Baseline Alpha-Fetoprotein

UPDATED

Avignon 84918

A Phase 3 clinical study for patients with Hepatocellular Carcinoma and Elevated Baseline Alpha-Fetoprotein

UPDATED

Besancon 25030

A Phase 3 clinical study for patients with Hepatocellular Carcinoma and Elevated Baseline Alpha-Fetoprotein

UPDATED

Caen 14033

A Phase 3 clinical study for patients with Hepatocellular Carcinoma and Elevated Baseline Alpha-Fetoprotein

UPDATED

Clermont-Ferrand 63003

A Phase 3 clinical study for patients with Hepatocellular Carcinoma and Elevated Baseline Alpha-Fetoprotein

View More ▼

UPDATED

Clichy 92110

A clinical trial to evaluate treatments using PDR001 and Sorafenib for patients with Hepatocellular Carcinoma

UPDATED

Lyon 69317

A Phase 3 clinical study for patients with Hepatocellular Carcinoma and Elevated Baseline Alpha-Fetoprotein

UPDATED

Montpellier 34295

A Phase 3 clinical study for patients with Hepatocellular Carcinoma and Elevated Baseline Alpha-Fetoprotein

UPDATED

Nantes 44093

A Phase 3 clinical study for patients with Hepatocellular Carcinoma and Elevated Baseline Alpha-Fetoprotein

UPDATED

Pessac 33604

A Phase 3 clinical study for patients with Hepatocellular Carcinoma and Elevated Baseline Alpha-Fetoprotein

UPDATED

Poitiers 86021

A Phase 3 clinical study for patients with Hepatocellular Carcinoma and Elevated Baseline Alpha-Fetoprotein

UPDATED

Rennes 35062

A Phase 3 clinical study for patients with Hepatocellular Carcinoma and Elevated Baseline Alpha-Fetoprotein

UPDATED

Saint Etienne 42055

A Phase 3 clinical study for patients with Hepatocellular Carcinoma and Elevated Baseline Alpha-Fetoprotein

Germany

UPDATED

Bayern 81377

A Phase 3 clinical study for patients with Hepatocellular Carcinoma and Elevated Baseline Alpha-Fetoprotein

UPDATED

Berlin 13125

A Phase 3 clinical study for patients with Hepatocellular Carcinoma and Elevated Baseline Alpha-Fetoprotein

UPDATED

Bielefeld 33611

A Phase 3 clinical study for patients with Hepatocellular Carcinoma and Elevated Baseline Alpha-Fetoprotein

UPDATED

Erlangen 91054

A Phase 3 clinical study for patients with Hepatocellular Carcinoma and Elevated Baseline Alpha-Fetoprotein

UPDATED

Essen 45147

A clinical trial to evaluate treatments using PDR001 and Sorafenib for patients with Hepatocellular Carcinoma

View More ▼

UPDATED

Essen 45122

A Phase 3 clinical study for patients with Hepatocellular Carcinoma and Elevated Baseline Alpha-Fetoprotein

UPDATED

Frankfurt 60590

A Phase 3 clinical study for patients with Hepatocellular Carcinoma and Elevated Baseline Alpha-Fetoprotein

UPDATED

Hamburg 20246

A Phase 3 clinical study for patients with Hepatocellular Carcinoma and Elevated Baseline Alpha-Fetoprotein